Conference Papers
Year : 2022
Joseph Ciccolini : Connect in order to contact the contributor
https://inria.hal.science/hal-03939669
Submitted on : Sunday, January 15, 2023-11:44:55 AM
Last modification on : Wednesday, November 6, 2024-10:50:02 AM
Dates and versions
Identifiers
- HAL Id : hal-03939669 , version 1
Cite
Joseph Ciccolini. TDM of oral targeted therapies: is it worth it?. ESMO, European Society of Medical Oncology, Sep 2022, Paris, France. ⟨hal-03939669⟩
27
View
0
Download